"Centre hospitalier universitaire (CHU) de Besançon. Etablissement public de santé, qui assure une triple mission : soins, enseignement et recherche."

During the past decade, HOPITAL JEAN MINJOZ; Oncologie conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 15 clinical trials were completed, i.e. on average, 136.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "HOPITAL JEAN MINJOZ; Oncologie" #1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator, "Institut de Recherches Internationales Servier" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "HOPITAL JEAN MINJOZ; Oncologie" are "Breast Cancer" (8 trials), "Colorectal Cancer" (3 trials), "Breast Neoplasms" (2 trials), "Metastatic Colorectal Cancer" (2 trials) and "Castration-Resistant Prostatic Cancer" (1 trials). Many other conditions were trialed in "HOPITAL JEAN MINJOZ; Oncologie" in a lesser frequency.

Most popular intervention types in "HOPITAL JEAN MINJOZ; Oncologie" are "Drug" (19 trials), "Radiation" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (7 trials), "Trastuzumab" (5 trials), "Docetaxel" (4 trials), "Pertuzumab" (4 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "HOPITAL JEAN MINJOZ; Oncologie" are 19 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "HOPITAL JEAN MINJOZ; Oncologie". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in HOPITAL JEAN MINJOZ; Oncologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in HOPITAL JEAN MINJOZ; Oncologie, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".